Project Grant HT94252410519
- This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
- This federal Project Grant award of $2,519,334.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) with a performance period from July 1, 2025 to June 30, 2029. The purpose of this award is to develop and conduct a clinical trial of an AI-facilitated, web-based written exposure therapy training program to increase the reach of evidence-based PTSD treatment. The award recipient, The University of Texas Health Science Center at San...
- This federal Project Grant award of $3,150,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a randomized clinical trial that uses noninvasive brain stimulation combined with written exposure therapy for post-traumatic stress disorder (PTSD) in military personnel with mild traumatic brain injury. The award recipient is the University of Texas Health Science Center at San Antonio (UTHSCSA), a prominent Hispanic-serving academic...
- This Project Grant award, totaling $10,009,861.88, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports two key products or services: A randomized controlled multisite clinical trial evaluating a portable near-infrared hematoma imager for detection of intracranial hemorrhage in acute care settings. This trial will assess the efficacy and feasibility of this medical imaging technology. A randomized controlled...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $6,964,861.00 to The University of Texas Health Science Center at San Antonio to conduct a multi-year longitudinal study focused on military psychological health. The study has five specific aims: Conduct a prospective, longitudinal follow-up of 3,360 previous clinical trial participants treated for PTSD, sleep disorders, or chronic pain. Conduct a...
- This $2,346,267 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Texas Health Science Center at Houston (UTHealth) to evaluate a technology-enhanced, entirely remote 2-week integrated treatment for pain and post-traumatic stress disorder (PTSD). The research project, titled "Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced Entirely Remote 2-Week...
- This federal Project Grant award of $2,993,024.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of lethal means safety counseling for service members and civilians with post-traumatic stress disorder (PTSD). The study, titled "FIREARM SAFETY IN PTSD (FASP): A RANDOMIZED CONTROLLED TRIAL OF LETHAL MEANS SAFETY COUNSELING AMONG SERVICE MEMBERS AND CIVILIANS WITH PTSD", will be conducted by...
- This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
- The University of Texas Health Science Center at Houston (UTHealth) received a $3,845,822 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to conduct a comparative effectiveness study on transdiagnostic behavior therapy versus treatment-as-usual for adjustment disorder following traumatic event exposure. The award runs from July 1, 2024 to June 30, 2028. The federal grant supports innovative biomedical research initiatives aimed at...
- This federal Project Grant award of $905,863.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Illinois in Chicago. The award supports advanced biomedical research aimed at understanding the role of neuroactive steroids and dynamic GABAA receptor reconfiguration in postpartum depression. The 4-year project, running from May 1, 2025 to April 30, 2029, will contribute to transforming healthcare for military...
This Project Grant award, with a total funding of $3,002,873.00, was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The purpose of the grant is to conduct a randomized clinical trial titled "ASPIRED: ALLEVIATING SUICIDALITY BY COMBINING PSYCHOTHERAPY AND IM KETAMINE FOR RAPID TREATMENT IN THE EMERGENCY DEPARTMENT". The University of Texas Health Science Center at San Antonio (UTHSCSA) is the prime grantee for this award, which has a performance period from Sep 30, 2024 to Sep 29, 2028. Under this grant, UTHSCSA will lead research efforts to investigate a novel treatment approach combining psychotherapy and ketamine infusion for rapidly alleviating suicidality in the emergency department setting. The results of this clinical trial are expected to provide valuable insights into improving mental health outcomes for military service members, veterans, and the broader population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $3.0m | 5/2/24 |